Loading clinical trials...
Loading clinical trials...
The objective of this randomized safety and observational study is to demonstrate CorPath GRX chronic total occlusion PCI is safe, and that Cardiac Catheterization Laboratory staff have no additional ...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Siemens Healthineers Endovascular Robotics, Inc.
NCT07660419 · Coronary Artery Disease (CAD), Coronary Stenosis
NCT04695106 · Atrial Fibrillation, Antithrombotic Therapy, and more
NCT06779630 · Coronary Artery Disease
NCT06890312 · Coronary Angiography, Percutaneous Coronary Intervention, and more
NCT07565805 · Coronary Artery Disease (CAD)
St. Luke's Hospital of Kansas City
Kansas City, Missouri
WellSpan York Hospital
York, Pennsylvania
University of Washington
Seattle, Washington
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions